Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
NPJ Vaccines|March 26, 2026
Evaluating varicella-zoster virus vaccine immunogenicity through Fc-mediated antibody functions: the roles of ADCP and ADCCSivilay Xayaheuang, Ji-Young Hwang, Yunhwa Kim, et al.
Virulence|September 6, 2017
Altered virulence of Highly Pathogenic Avian Influenza (HPAI) H5N8 reassortant viruses in mammalian modelsSu-Jin Park, Eun-Ha Kim, Hyeok-Il Kwon, et al.
Virology|August 21, 2016
Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virusSu-Jin Park, Young-Jae Si, Jihye Kim, et al.
The Oncologist|June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ HybridizationSiraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
NPJ Precision Oncology|January 24, 2025
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinomaSandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, et al.
Hepatology (Baltimore, Md.)|August 9, 2022
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironmentsDaniel J Zabransky, Ludmila Danilova, James M Leatherman, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 TherapyJiang Chen, Zohreh Amoozgar, Xin Liu, et al.
The Journal of Pediatrics|October 10, 2018
Factors Associated with Adverse Outcomes among Febrile Young Infants with Invasive Bacterial InfectionsChristopher M Pruitt, Mark I Neuman, Samir S Shah, et al.
Science Translational Medicine|July 5, 2013
Natural selection in a bangladeshi population from the cholera-endemic ganges river deltaElinor K Karlsson, Jason B Harris, Shervin Tabrizi, et al.
Annals of Surgical Oncology|January 16, 2026
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical TrialsAmber F Gallanis, Shruthi R Perati, Stephanie N Canady, et al.
Pageof 15